(Press-News.org) (Monday, 30 June 2025, London, United Kingdom) A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress 2025, the new technology could pave the way for more effective and less invasive treatment options for people living with type 1 diabetes (T1D).1
The breakthrough involved printing human islets – the insulin-producing clusters of cells in the pancreas – using a customised bioink made from alginate and decellularised human pancreatic tissue. This approach produced durable, high-density islet structures that remained alive and functional for up to three weeks, maintaining strong insulin responses to glucose and showing real potential for future clinical use.2
Traditional islet transplants are typically infused into the liver, a process that can result in significant loss of cells and limited long-term success. In contrast, the 3D-printed islets in this study were designed to be implanted just under the skin, a simple procedure requiring only local anaesthesia and a small incision. This minimally invasive approach could offer a safer and more comfortable option for patients.3
“Our goal was to recreate the natural environment of the pancreas so that transplanted cells would survive and function better,” explained lead author Dr. Quentin Perrier. “We used a special bioink that mimics the support structure of the pancreas, giving islets the oxygen and nutrients they need to thrive.”
To keep the fragile human islets safe during printing, the team created a gentler way to print by fine-tuning key settings – using low pressure (30 kPa) and a slow print speed (20 mm per minute). This careful approach reduced physical stress on the islets and helped keep their natural shape, solving a major problem that had held back earlier bioprinting attempts.
In laboratory tests, the bioprinted islets stayed alive and healthy, with over 90% cell survival. They also responded better to glucose than standard islet preparations, releasing more insulin when it was needed. By day 21, the bioprinted islets showed a stronger ability to sense and react to blood sugar levels – an important sign that they could work well after being implanted. Importantly, the constructs maintained their structure without clumping or breaking down, overcoming a common hurdle in earlier approaches.
Additionally, the 3D-printed structures featured a porous architecture that enhanced the flow of oxygen and nutrients to the embedded islets. This design not only helped maintain cell health but also promoted vascularisation, both of which are critical for long-term survival and function after transplantation.
“This is one of the first studies to use real human islets instead of animal cells in bioprinting, and the results are incredibly promising,” noted Dr. Perrier. “It means we’re getting closer to creating an off-the-shelf treatment for diabetes that could one day eliminate the need for insulin injections.”
The team is now testing the bioprinted constructs in animal models and exploring long-term storage options, such as cryopreservation, that could make the therapy widely available. They are also working on adapting the method for alternative sources of insulin-producing cells to overcome donor shortages, including stem-cell-derived islets and xeno-islets (from pigs).
“While there is still work to be done, this new bioprinting method marks a critical step toward personalised, implantable therapies for diabetes. If clinical trials confirm its effectiveness, it could transform treatment and quality of life for millions of people worldwide,” Dr. Perrier concluded.
Note to editors:
A reference to the ESOT Congress 2025 must be included in all coverage and/or articles associated with this study.
For more information or to arrange an expert interview, please contact Luke Paskins on press@esot.org.
About the study author:
Dr. Quentin Perrier is a rising star in beta cell replacement. His research focuses on the application of cutting-edge, regenerative medicine-inspired biotechnologies to islet transplantation. He is conducting groundbreaking research at the Wake Forest University School of Medicine, in the United States, under the mentorship of Professors Amish Asthana, Alice Tomei, Sang Jin Lee and Giuseppe Orlando.
Coinvestigators in the research endeavour were Wonwoo Jeong, Arunkumar Rengaraj, Lori N Byers, Grisell Gonzalez, Emma Peveri, Jake Miller, Rita Bottino, Alexei V. Mikhailov, Christopher Fraker, Emmanuel C Opara, Alice Tomei, Sang Jin Lee, Giuseppe Orlando, and Amish Asthana.
The research was funded by Breakthrough T1D, formerly JDRF (PI: Giuseppe Orlando).
About ESOT:
The European Society for Organ Transplantation (ESOT) was founded 40 years ago and is dedicated to the pursuit of excellence in organ transplantation. Facilitating a wealth of international clinical trials and research collaborations over the years, ESOT remains committed to its primary aim of improving patient outcomes in transplantation. With a community of over 8000 members from around the world, ESOT is an influential international organisation and the facilitator of the biennial congress which hosts approximately 3500 experts who come to meet to explore and discuss the latest scientific research.
References:
Perrier Q., Jeong, W., Rengaraj, A., et al. Breakthrough in 3D printing: Functional human islets in an alginate-decm bioink. Presented at ESOT Congress 2025; 30 June 2025; London, UK.
Asthana, A., Amanda, E., Suárez, G., Lozano, T., N Byers, L., Ho-Heo, J., Jeong, W., Tamburrini, T., Rengaraj, A., Chaimov, D., Perrier, Q., Tomei, A., A Fraker, A., Jin Lee, S., Orlando, G. Comprehensive biocompatibility profiling of human pancreas-derived biomaterial. Front. Bioeng. Biotechnol., Sec. Tissue Engineering and Regenerative Medicine, Volume 13 - 2025, doi: 10.3389/fbioe.2025.151866 https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2025.1518665/full
Rajkumari, N., Shalayel, I., Tubbs, E., Perrier, Q., Chabert C., Lablanche, S., Benhamou, P., Arnol C., Gredy, L., Divoux, T., Stephan, O., Zebda, A., van der Sanden, B. Matrix design for optimal pancreatic β cells transplantation. Biomaterials Advances, Volume 164, November 2024, 213980 END
Even small drops in national income can significantly increase the risk of various forms of childhood malnutrition- not only undernutrition but also overweight and obesity, shows a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation. The study, published in Lancet Global Health, identifies pregnancy and the first 1,000 days of life as especially vulnerable periods where targeted interventions can make a big difference.
One in four children worldwide lives in severe food poverty. And many low- and middle-income countries ...
A study by the Center for Redox Processes in Biomedicine (Redoxoma) led by Marilene Demasi from the Butantan Institute (São Paulo, Brazil) presents a valuable new experimental model for investigating the interaction between the proteasome and mitochondrial function. In eukaryotic cells, the proteasome is a protein complex responsible for eliminating damaged and nonfunctional proteins, thereby helping to maintain cellular balance and proper functioning.
In recent years, studies have revealed that the proteasome ...
Spinal cord injuries are currently incurable with devastating effects on people’s lives, but now a trial at Waipapa Taumata Rau, University of Auckland offers hope for an effective treatment.
Spinal cord injuries shatter the signal between the brain and body, often resulting in a loss of function.“Unlike a cut on the skin, which typically heals on its own, the spinal cord does not regenerate effectively, making these injuries devastating and currently incurable,” says lead researcher Dr Bruce Harland, a senior research fellow in the School of Pharmacy at Waipapa Taumata Rau, University of Auckland.
Before birth, and to a lesser extent afterwards, ...
Urea is one of the most important industrial chemicals produced worldwide. It is used as a fertiliser, for the production of synthetic resins and explosives and as a fuel additive for cleaning car exhaust gases. Urea is also believed to be a potential key building block for the formation of biological molecules such as RNA and DNA in connection with the question of the origin of life (see ETH News from 28 June 2023). Until now, the origin of urea itself on Early Earth has not been conclusively clarified.
A research team led by Ruth Signorell, Professor of Physical Chemistry ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan — a transformative advance in early, accurate diagnosis.
The tool, StateViewer, helped researchers identify the dementia type in 88% of cases, according to research published online on June 27, 2025, in Neurology, the medical journal of the American Academy of Neurology. It also enabled clinicians to interpret brain scans ...
(MEMPHIS, Tenn. – June 27, 2025) Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children’s Research Hospital. Many people with sickle cell disease experience increased brain ischemia, where oxygen is not delivered properly to brain tissues, potentially leading to strokes. A part of the risk for these events comes from increased blood flow speed in the brain. Findings from three patients in a gene therapy clinical trial showed ...
Human breast milk is uniquely adapted to meet an infant’s nutritional needs. Surprisingly, we still know very little about how milk is even made in the breast. A team of ETH Zurich researchers led by Marcy Zenobi-Wong, Professor of Tissue Engineering and Biofabrication, want to change that. In the lab, Zenobi-Wong and her team developed tiny replicas of lactating breast tissue. This involved isolating cells from human breast milk that are naturally found in milk. Some of the cells from lactating breast tissue and the so-called lactocytes – the cells in breast tissue that produce milk – end up in ...
COLUMBUS, Ohio – While emerging evidence suggests pesticides can be toxic to the mix of microorganisms in the digestive system, a new study is the first to map changes to specific gut bacteria based on interactions between human microbes and insect-killing chemicals observed in the lab and an animal model.
The analysis showed that over a dozen pesticides influence human gut bacteria growth patterns, affect how gut microorganisms process nutrients and camp out inside some bacteria. Researchers say the resulting “atlas” ...
New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL). Scientists at St. Jude Children’s Research Hospital and University Health Network’s Princess Margaret Cancer Centre, Toronto, developed a robust single-cell reference atlas of normal human B-cell development and cross-referenced single-cell B-ALL data with it, as well as outcomes data. The study, ...
Roberto Morandotti Wins Prestigious IEEE Photonics Society Quantum Electronics Award
Congratulations to Professor Roberto Morandotti, the first researcher at INRS to receive this prestigious award in the field of quantum electronics
VARENNES, QC, June 27, 2025 – Professor Roberto Morandotti, a globally recognized leader in quantum optics and photonics at the Institut national de la recherche scientifique (INRS), has won the 2025 Institute of Electrical and Electronics Engineers (IEEE) Photonic Society Quantum Electronics Award. This award pays ...
